Comparative study of timolol gel versus timolol solution for patients with glaucoma

S. H. Chiou, Wen-Ming Hsu, J. H. Liu, J. L. Liu, M. R. Chen, D. C. Tsai, C. K. Chou

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background. The timolol gel was developed for the simplification of multi-dose medications for glaucoma patients. This gel can be used once per day instead of twice per day of the equeous form. It is necessary to understand the clinical effects of intraocular pressure maintained in glaucoma by there two forms of timolol. Methods. Fifty-two eligible patients were included and completed the 12-week study. In this randomized, open-label, two-period crossover study design, patients received either the gel form of 0.5% timolol once daily or the aqueous form of 0.5% timolol twice daily for the first 6 weeks, then crossed over to the other treatment form for the remaining 6 weeks. Intraocular pressure was measured at baseline, week 6 and week 12 at the end of the treatment period. The incidences of all the adverse events were recorded and summarized in each follow-up visit. Results. No statistically significant difference in intraocular pressure was observed between the two different control treatment groups (p > 0.05). However, stickiness and transient blurred vision was reported more often by patients using the gel form than the aqueous form of timolol. Conclusions. The gel form of 0.5% timolol used once daily offers a new alternative that is probably more convenient than the aqueous form of 0.5% timolol given twice daily in maintaining the intraocular pressure of patients with glaucoma.

Original languageEnglish
Pages (from-to)737-743
Number of pages7
JournalChinese Medical Journal (Taipei)
Volume63
Issue number10
Publication statusPublished - Nov 20 2000
Externally publishedYes

Fingerprint

Timolol
Glaucoma
Gels
Intraocular Pressure
Cross-Over Studies
Therapeutics
Control Groups
Incidence

Keywords

  • Glaucoma
  • Intraocular pressure
  • Timolol

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chiou, S. H., Hsu, W-M., Liu, J. H., Liu, J. L., Chen, M. R., Tsai, D. C., & Chou, C. K. (2000). Comparative study of timolol gel versus timolol solution for patients with glaucoma. Chinese Medical Journal (Taipei), 63(10), 737-743.

Comparative study of timolol gel versus timolol solution for patients with glaucoma. / Chiou, S. H.; Hsu, Wen-Ming; Liu, J. H.; Liu, J. L.; Chen, M. R.; Tsai, D. C.; Chou, C. K.

In: Chinese Medical Journal (Taipei), Vol. 63, No. 10, 20.11.2000, p. 737-743.

Research output: Contribution to journalArticle

Chiou, SH, Hsu, W-M, Liu, JH, Liu, JL, Chen, MR, Tsai, DC & Chou, CK 2000, 'Comparative study of timolol gel versus timolol solution for patients with glaucoma', Chinese Medical Journal (Taipei), vol. 63, no. 10, pp. 737-743.
Chiou, S. H. ; Hsu, Wen-Ming ; Liu, J. H. ; Liu, J. L. ; Chen, M. R. ; Tsai, D. C. ; Chou, C. K. / Comparative study of timolol gel versus timolol solution for patients with glaucoma. In: Chinese Medical Journal (Taipei). 2000 ; Vol. 63, No. 10. pp. 737-743.
@article{c71b8dfc8aae41adbc76e30ca3c2d23f,
title = "Comparative study of timolol gel versus timolol solution for patients with glaucoma",
abstract = "Background. The timolol gel was developed for the simplification of multi-dose medications for glaucoma patients. This gel can be used once per day instead of twice per day of the equeous form. It is necessary to understand the clinical effects of intraocular pressure maintained in glaucoma by there two forms of timolol. Methods. Fifty-two eligible patients were included and completed the 12-week study. In this randomized, open-label, two-period crossover study design, patients received either the gel form of 0.5{\%} timolol once daily or the aqueous form of 0.5{\%} timolol twice daily for the first 6 weeks, then crossed over to the other treatment form for the remaining 6 weeks. Intraocular pressure was measured at baseline, week 6 and week 12 at the end of the treatment period. The incidences of all the adverse events were recorded and summarized in each follow-up visit. Results. No statistically significant difference in intraocular pressure was observed between the two different control treatment groups (p > 0.05). However, stickiness and transient blurred vision was reported more often by patients using the gel form than the aqueous form of timolol. Conclusions. The gel form of 0.5{\%} timolol used once daily offers a new alternative that is probably more convenient than the aqueous form of 0.5{\%} timolol given twice daily in maintaining the intraocular pressure of patients with glaucoma.",
keywords = "Glaucoma, Intraocular pressure, Timolol",
author = "Chiou, {S. H.} and Wen-Ming Hsu and Liu, {J. H.} and Liu, {J. L.} and Chen, {M. R.} and Tsai, {D. C.} and Chou, {C. K.}",
year = "2000",
month = "11",
day = "20",
language = "English",
volume = "63",
pages = "737--743",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "10",

}

TY - JOUR

T1 - Comparative study of timolol gel versus timolol solution for patients with glaucoma

AU - Chiou, S. H.

AU - Hsu, Wen-Ming

AU - Liu, J. H.

AU - Liu, J. L.

AU - Chen, M. R.

AU - Tsai, D. C.

AU - Chou, C. K.

PY - 2000/11/20

Y1 - 2000/11/20

N2 - Background. The timolol gel was developed for the simplification of multi-dose medications for glaucoma patients. This gel can be used once per day instead of twice per day of the equeous form. It is necessary to understand the clinical effects of intraocular pressure maintained in glaucoma by there two forms of timolol. Methods. Fifty-two eligible patients were included and completed the 12-week study. In this randomized, open-label, two-period crossover study design, patients received either the gel form of 0.5% timolol once daily or the aqueous form of 0.5% timolol twice daily for the first 6 weeks, then crossed over to the other treatment form for the remaining 6 weeks. Intraocular pressure was measured at baseline, week 6 and week 12 at the end of the treatment period. The incidences of all the adverse events were recorded and summarized in each follow-up visit. Results. No statistically significant difference in intraocular pressure was observed between the two different control treatment groups (p > 0.05). However, stickiness and transient blurred vision was reported more often by patients using the gel form than the aqueous form of timolol. Conclusions. The gel form of 0.5% timolol used once daily offers a new alternative that is probably more convenient than the aqueous form of 0.5% timolol given twice daily in maintaining the intraocular pressure of patients with glaucoma.

AB - Background. The timolol gel was developed for the simplification of multi-dose medications for glaucoma patients. This gel can be used once per day instead of twice per day of the equeous form. It is necessary to understand the clinical effects of intraocular pressure maintained in glaucoma by there two forms of timolol. Methods. Fifty-two eligible patients were included and completed the 12-week study. In this randomized, open-label, two-period crossover study design, patients received either the gel form of 0.5% timolol once daily or the aqueous form of 0.5% timolol twice daily for the first 6 weeks, then crossed over to the other treatment form for the remaining 6 weeks. Intraocular pressure was measured at baseline, week 6 and week 12 at the end of the treatment period. The incidences of all the adverse events were recorded and summarized in each follow-up visit. Results. No statistically significant difference in intraocular pressure was observed between the two different control treatment groups (p > 0.05). However, stickiness and transient blurred vision was reported more often by patients using the gel form than the aqueous form of timolol. Conclusions. The gel form of 0.5% timolol used once daily offers a new alternative that is probably more convenient than the aqueous form of 0.5% timolol given twice daily in maintaining the intraocular pressure of patients with glaucoma.

KW - Glaucoma

KW - Intraocular pressure

KW - Timolol

UR - http://www.scopus.com/inward/record.url?scp=0033759477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033759477&partnerID=8YFLogxK

M3 - Article

C2 - 11076430

AN - SCOPUS:0033759477

VL - 63

SP - 737

EP - 743

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 10

ER -